1. Home
  2. PFSA vs HBIO Comparison

PFSA vs HBIO Comparison

Compare PFSA & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFSA
  • HBIO
  • Stock Information
  • Founded
  • PFSA 2009
  • HBIO 1901
  • Country
  • PFSA United States
  • HBIO United States
  • Employees
  • PFSA N/A
  • HBIO N/A
  • Industry
  • PFSA Medical/Dental Instruments
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • PFSA Health Care
  • HBIO Industrials
  • Exchange
  • PFSA Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • PFSA 25.1M
  • HBIO 24.6M
  • IPO Year
  • PFSA N/A
  • HBIO 2000
  • Fundamental
  • Price
  • PFSA $0.68
  • HBIO $0.56
  • Analyst Decision
  • PFSA
  • HBIO Buy
  • Analyst Count
  • PFSA 0
  • HBIO 2
  • Target Price
  • PFSA N/A
  • HBIO $3.00
  • AVG Volume (30 Days)
  • PFSA 1.6M
  • HBIO 1.4M
  • Earning Date
  • PFSA 01-01-0001
  • HBIO 08-11-2025
  • Dividend Yield
  • PFSA N/A
  • HBIO N/A
  • EPS Growth
  • PFSA N/A
  • HBIO N/A
  • EPS
  • PFSA N/A
  • HBIO N/A
  • Revenue
  • PFSA $75,000.00
  • HBIO $91,397,000.00
  • Revenue This Year
  • PFSA N/A
  • HBIO N/A
  • Revenue Next Year
  • PFSA N/A
  • HBIO $9.75
  • P/E Ratio
  • PFSA N/A
  • HBIO N/A
  • Revenue Growth
  • PFSA 150.00
  • HBIO N/A
  • 52 Week Low
  • PFSA $0.65
  • HBIO $0.28
  • 52 Week High
  • PFSA $5.50
  • HBIO $3.45
  • Technical
  • Relative Strength Index (RSI)
  • PFSA N/A
  • HBIO 64.20
  • Support Level
  • PFSA N/A
  • HBIO $0.39
  • Resistance Level
  • PFSA N/A
  • HBIO $0.64
  • Average True Range (ATR)
  • PFSA 0.00
  • HBIO 0.04
  • MACD
  • PFSA 0.00
  • HBIO 0.01
  • Stochastic Oscillator
  • PFSA 0.00
  • HBIO 69.88

About PFSA Profusa Inc. Common Stock

Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: